These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 19116337)

  • 1. Minireview: 3-Iodothyronamine (T1AM): a new player on the thyroid endocrine team?
    Scanlan TS
    Endocrinology; 2009 Mar; 150(3):1108-11. PubMed ID: 19116337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3-Iodothyronamine (T(1)AM): a new chapter of thyroid hormone endocrinology?
    Ianculescu AG; Scanlan TS
    Mol Biosyst; 2010 Aug; 6(8):1338-44. PubMed ID: 20623079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regioselective deiodination of iodothyronamines, endogenous thyroid hormone derivatives, by deiodinase mimics.
    Mondal S; Mugesh G
    Chemistry; 2014 Aug; 20(35):11120-8. PubMed ID: 25060228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternate pathways of thyroid hormone metabolism.
    Wu SY; Green WL; Huang WS; Hays MT; Chopra IJ
    Thyroid; 2005 Aug; 15(8):943-58. PubMed ID: 16131336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3-Iodothyronamine Decreases Expression of Genes Involved in Iodide Metabolism in Mouse Thyroids and Inhibits Iodide Uptake in PCCL3 Thyrocytes.
    Schanze N; Jacobi SF; Rijntjes E; Mergler S; Del Olmo M; Hoefig CS; Khajavi N; Lehmphul I; Biebermann H; Mittag J; Köhrle J
    Thyroid; 2017 Jan; 27(1):11-22. PubMed ID: 27788620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biosynthesis of 3-iodothyronamine (T1AM) is dependent on the sodium-iodide symporter and thyroperoxidase but does not involve extrathyroidal metabolism of T4.
    Hackenmueller SA; Marchini M; Saba A; Zucchi R; Scanlan TS
    Endocrinology; 2012 Nov; 153(11):5659-67. PubMed ID: 22948220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-Iodothyronamine metabolism and functional effects in FRTL5 thyroid cells.
    Agretti P; De Marco G; Russo L; Saba A; Raffaelli A; Marchini M; Chiellini G; Grasso L; Pinchera A; Vitti P; Scanlan TS; Zucchi R; Tonacchera M
    J Mol Endocrinol; 2011 Aug; 47(1):23-32. PubMed ID: 21511808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyronamines and Derivatives: Physiological Relevance, Pharmacological Actions, and Future Research Directions.
    Hoefig CS; Zucchi R; Köhrle J
    Thyroid; 2016 Dec; 26(12):1656-1673. PubMed ID: 27650974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biosynthesis of 3-Iodothyronamine From T4 in Murine Intestinal Tissue.
    Hoefig CS; Wuensch T; Rijntjes E; Lehmphul I; Daniel H; Schweizer U; Mittag J; Köhrle J
    Endocrinology; 2015 Nov; 156(11):4356-64. PubMed ID: 26348473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory action of iodothyronines on the thyroid. Possible role in the autoregulatory mechanism.
    Pisarev MA; Juvenal GJ; Kleiman de Pisarev DL
    Prog Clin Biol Res; 1981; 74():103-14. PubMed ID: 6172797
    [No Abstract]   [Full Text] [Related]  

  • 11. Uptake and metabolic effects of 3-iodothyronamine in hepatocytes.
    Ghelardoni S; Chiellini G; Frascarelli S; Saba A; Zucchi R
    J Endocrinol; 2014 Apr; 221(1):101-10. PubMed ID: 24627446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyronamines are isozyme-specific substrates of deiodinases.
    Piehl S; Heberer T; Balizs G; Scanlan TS; Smits R; Koksch B; Köhrle J
    Endocrinology; 2008 Jun; 149(6):3037-45. PubMed ID: 18339710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyronamines are substrates for human liver sulfotransferases.
    Pietsch CA; Scanlan TS; Anderson RJ
    Endocrinology; 2007 Apr; 148(4):1921-7. PubMed ID: 17204552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central effects of thyronamines on glucose metabolism in rats.
    Klieverik LP; Foppen E; Ackermans MT; Serlie MJ; Sauerwein HP; Scanlan TS; Grandy DK; Fliers E; Kalsbeek A
    J Endocrinol; 2009 Jun; 201(3):377-86. PubMed ID: 19273499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for extrathyroidal formation of 3-iodothyronamine in humans as provided by a novel monoclonal antibody-based chemiluminescent serum immunoassay.
    Hoefig CS; Köhrle J; Brabant G; Dixit K; Yap B; Strasburger CJ; Wu Z
    J Clin Endocrinol Metab; 2011 Jun; 96(6):1864-72. PubMed ID: 21490071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of 3-iodothyronamine (3-T
    Li ZM; Miller M; Gachkar S; Mittag J; Schriever SC; Pfluger PT; Schramm KW; De Angelis M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Feb; 1165():122553. PubMed ID: 33503577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac effects of thyronamines.
    Zucchi R; Ghelardoni S; Chiellini G
    Heart Fail Rev; 2010 Mar; 15(2):171-6. PubMed ID: 19016324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3-Iodothyronamine: a modulator of the hypothalamus-pancreas-thyroid axes in mice.
    Manni ME; De Siena G; Saba A; Marchini M; Dicembrini I; Bigagli E; Cinci L; Lodovici M; Chiellini G; Zucchi R; Raimondi L
    Br J Pharmacol; 2012 May; 166(2):650-8. PubMed ID: 22225569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3-Iodothyronamine: a novel hormone controlling the balance between glucose and lipid utilisation.
    Braulke LJ; Klingenspor M; DeBarber A; Tobias SC; Grandy DK; Scanlan TS; Heldmaier G
    J Comp Physiol B; 2008 Feb; 178(2):167-77. PubMed ID: 17912534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the thyroid hormone derivatives 3-iodothyronamine and thyronamine on rat liver oxidative capacity.
    Venditti P; Napolitano G; Di Stefano L; Chiellini G; Zucchi R; Scanlan TS; Di Meo S
    Mol Cell Endocrinol; 2011 Jul; 341(1-2):55-62. PubMed ID: 21664427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.